IPO
Kairos Pharma Prices $6.2 Million Initial Public Offering
Kairos Pharma Ltd.
PR-09-24-NI-05Sep 16, 2024
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02Jun 24, 2022
Column: Investment
2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out
Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-07Mar 23, 2022
IPO
Erasca Announces Pricing of Upsized Initial Public Offering
Erasca
PR-M07-21-09Jul 20, 2021
IPO
NeuroPace, Inc. Announces Pricing of Initial Public Offering
Nice Insight
PR-M04-21-022Apr 21, 2021
IPO
GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering
GRAIL
PR-M09-20-NI-13-1304Sep 09, 2020
Investment
Mirum Pharmaceuticals Files for IPO
Nice Insight
PAO-M07-19-NI-001Jul 01, 2019
IPO
BridgeBio Pharma Announces Pricing of Its Initial Public Offering
BridgeBio Pharma
PR-M06-19-NI-060Jun 28, 2019
IPO
Stealth BioTherapeutics Announces Pricing of Initial Public Offering
Stealth BioTherapeutics
PR-M02-19-NI-042Feb 20, 2019
Investment
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1
China SXT Pharmaceuticals, Inc.
PR-M10-18-NI-017Oct 04, 2018
Investment
The Biotech Boom
Emilie Branch
Pharma's Almanac
PAP-Q3-18-NI-003Oct 02, 2018
IPO
Titan Pharmaceuticals Prices $9,500,000 Public Offering
Titan Pharmaceuticals
PR-M09-18-NI-093Sep 28, 2018